Overview Repeat Dose Safety Study for Compound to Treat Asthma Status: Completed Trial end date: 1969-12-31 Target enrollment: Participant gender: Summary The purpose of this study is to describe the safety and tolerability of single and repeat oral doses of GSK1440115 in healthy volunteers. Phase: Phase 1 Details Lead Sponsor: Accenture